Omnicell, Inc.

Omnicell, Inc. is a healthcare technology company that provides solutions for medication management and supply chain optimization. Its offerings include automated dispensing systems like Titan XT and XTExtend, central pharmacy automation, IV compounding services, and specialty pharmacy services. The company also provides the EnlivenHealth platform for retail pharmacies, medication adherence solutions, and professional services such as training and implementation. Omnicell's products aim to improve clinician workflows, enhance patient safety, and enable full traceability of medicines and medical supplies across healthcare systems. Its cloud-based platform, OmniSphere, supports data integration and analytics. The company serves hospitals, health systems, and retail pharmacies in the United States and globally.

Omnicell, Inc. is listed on the Nasdaq Global Select Market (NasdaqGS) under the ticker symbol OMCL. Its shares are traded in United States Dollars (USD). The company is headquartered in Fort Worth, Texas, and its stock is part of the US equity market, making it accessible to investors through major brokerage platforms that trade on US exchanges.

Omnicell operates in the Healthcare sector, specifically within the Health Information Services industry. This classification reflects its focus on providing technology-driven solutions for medication management, pharmacy automation, and healthcare data integration. As a health information services company, Omnicell develops software and hardware products that help healthcare providers streamline clinical workflows, ensure medication safety, and improve operational efficiency. Its offerings bridge the gap between clinical care and information technology, supporting hospitals, health systems, and retail pharmacies in managing medications and supplies more effectively.

Omnicell, Inc. is headquartered in Fort Worth, Texas, United States. The company was incorporated in 1992 and originally known as Omnicell Technologies, Inc. before rebranding in 2001. It serves customers primarily in the United States and globally, providing healthcare technology solutions to hospitals, health systems, and retail pharmacies. Its products and services are designed to address medication management challenges across various healthcare settings, including acute care hospitals, outpatient clinics, and community pharmacies. The company's global reach extends to international markets, though its core operations remain centered in the US.

Omnicell generates revenue through multiple streams, including the sale of hardware and software products, professional services, and ongoing support and maintenance. Its hardware products include automated dispensing cabinets (e.g., Titan XT), central pharmacy automation systems, and medication packaging systems. Software offerings include the EnlivenHealth platform for retail pharmacies and OmniSphere cloud-based platform for data management. The company also provides professional services such as technology implementation, customer education, training, and program management. Additionally, Omnicell earns recurring revenue from post-installation support and maintenance contracts, which include phone/web support, on-site service, parts, and software upgrades. Medication adherence consumables and packaging systems also contribute to its revenue.